Download PDF
Semin Thromb Hemost 2012; 38(02): 213-221
DOI: 10.1055/s-0032-1301418
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemostatic Properties of the Lymph: Relationships with Occlusion and Thrombosis

Giuseppe Lippi
1   U.O. di Diagnostica Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
,
Emmanuel J. Favaloro
2   Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia
,
Gianfranco Cervellin
3   U.O. di Pronto Soccorso e Medicina d'Urgenza, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
09 February 2012 (online)

    Permissions and Reprints

Abstract

Lymphatic thrombosis is a rare occurrence, and although its frequency is likely underestimated, its burden remains substantially lower than that of venous or arterial thrombosis. Current evidence suggests that despite measurable levels of fibrinogen, von Willebrand factor and other coagulation factors in the lymph, fibrin generation is substantially inhibited under physiological conditions, essentially making the lymph a hypocoagulable biological fluid. Although factor VIIa-tissue factor-catalyzed activation of factor X is possible in the lymph, fibrin generation is largely counteracted by the unavailability of cell surface anionic phospholipids such as those physiologically present on blood platelets, combined with only low levels of coagulation factors, and the strong inhibitory activity of heparin, antithrombin, and tissue factor pathway inhibitor. Enhanced fibrinolytic activity further contributes to reduce the development and growth of lymph clots. Nevertheless, lymphatic thrombosis is occasionally detected, especially in the thoracic duct, axillary, or inguinal lymphatics. Pathogenetic mechanisms are supported by the release of thromboplastin substances from the injured lymphatic endothelium accompanied by chronic obstruction of lymph flow in the presence of a hypercoagulable milieu, thereby mirroring the Virchow triad that otherwise characterizes venous thrombosis. In theory, any source of lymphatic vessel occlusion, such as internal obliteration, external compression, or increased lymphatic pressure, might predispose to localized lymphatic thrombosis. The leading pathologies that can trigger thrombosis in the lymphatic vessels include cancer (due to external compression, neoplastic obliteration of the lymphatic lumen by metastatic cells, or lymphatic dysfunction after lymph node dissection), infections (especially lymphatic filariasis or sustained by Chlamydia trachomatis, Mycobacterium tuberculosis, Treponema pallidum, or Streptococcus pyogenes), congestive heart failure, chronic edema and inflammation of the distal lower limb, complications of central venous catheterization, coronary artery bypass grafting, thoracic outlet syndrome, and amyloidosis.

Keywords

lymphatic thrombosis - vessel - lymph - coagulation
 

  • References

  • 1 Ambrose CT. Immunology’s first priority dispute—an account of the 17th-century Rudbeck-Bartholin feud. Cell Immunol 2006; 242 (1) 1-8
    CrossrefPubMedGoogle Scholar
  • 2 Eriksson G. [Olaus Rudbeck as scientist and professor of medicine]. Sven Med Tidskr 2004; 8 (1) 39-44
    PubMedGoogle Scholar
  • 3 Ambrose CT. Rudbeck’s complaint: a 17th-century Latin letter relating to basic immunology. Scand J Immunol 2007; 66 (4) 486-493
    CrossrefPubMedGoogle Scholar
  • 4 Ambrose CT. The priority dispute over the function of the lymphatic system and Glisson’s ghost (the 18th-century Hunter-Monro Feud). Cell Immunol 2007; 245 (1) 7-15
    CrossrefPubMedGoogle Scholar
  • 5 Olszewski WL. The lymphatic system in body homeostasis: physiological conditions. Lymphat Res Biol 2003; 1 (1) 11-21, discussion 21–24
    CrossrefPubMedGoogle Scholar
  • 6 Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 2003; 163 (2) 209-213
    CrossrefPubMedGoogle Scholar
  • 7 Olszewski WL. Contractility patterns of normal and pathologically changed human lymphatics. Ann N Y Acad Sci 2002; 979: 52-63, discussion 76–79
    CrossrefPubMedGoogle Scholar
  • 8 Schmid-Schönbein GW. The second valve system in lymphatics. Lymphat Res Biol 2003; 1 (1) 25-29, discussion 29–31
    CrossrefPubMedGoogle Scholar
  • 9 Lee S, Choi I, Hong YK. Heterogeneity and plasticity of lymphatic endothelial cells. Semin Thromb Hemost 2010; 36 (3) 352-361
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Ross MH, Furth J, Bigelow RR. Changes in cellular composition of the lymph caused by ionizing radiations. Blood 1952; 7 (4) 417-428
    PubMedGoogle Scholar
  • 11 Bierman HR, Byron Jr RL, Kelly KH , et al. The characteristics of thoracic duct lymph in man. J Clin Invest 1953; 32 (7) 637-649
    CrossrefPubMedGoogle Scholar
  • 12 Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, Malik AB. Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol 1987; 132 (1) 111-117
    CrossrefPubMedGoogle Scholar
  • 13 Opie EL. Thrombosis and occlusion of lymphatics. J Med Res 1913; 29 (1) 131-146
    PubMedGoogle Scholar
  • 14 Howell WH. The coagulation of the lymph. Am J Physiol 1914; 35: 483-491
    PubMedGoogle Scholar
  • 15 Brinkhous KM, Walker SA. Prothrombin and fibrinogen in lymph. Am J Physiol 1941; 132: 666-669
    PubMedGoogle Scholar
  • 16 Copley AL, Lalich JJ. Bleeding time, lymph time, and clot resistance in men. J Clin Invest 1942; 21 (2) 145-152
    CrossrefPubMedGoogle Scholar
  • 17 Fantl P, Nelson JF. Coagulation in lymph. J Physiol 1953; 122 (1) 33-37
    PubMedGoogle Scholar
  • 18 Blomstrand R, Nilsson IM, Dahlback O. Coagulation studies on human thoracic duct lymph. Scand J Clin Lab Invest 1963; 15: 248-254
    CrossrefPubMedGoogle Scholar
  • 19 Mayanskii DN, Minnibaev MM. A comparative study of the clotting power of the blood and lymph. Bull Exp Biol Med 1966; 62: 1097-1098
    CrossrefPubMedGoogle Scholar
  • 20 Kuznik BI, Budazhabon GB, Tsybikov NN. [Comparative characteristics of blood and lymph clotting and fibrinolytic activity]. Fiziol Zh SSSR Im I M Sechenova 1979; 65 (6) 867-871
    PubMedGoogle Scholar
  • 21 Kuznik BI, Mishchenko VP, Budazhabon GV, Tsybikov NN. [Effect of intravenous infusions of thrombin and heterogenous blood on lymph coagulability]. Fiziol Zh SSSR Im I M Sechenova 1976; 62 (10) 1460-1465
    PubMedGoogle Scholar
  • 22 Müller N, Danckworth HP. [Coagulation properties of the extravascular fluid. I. Coagulation factors in thoracic-duct lymph]. Z Lymphol 1980; 4 (1) 11-17
    PubMedGoogle Scholar
  • 23 Garaev GS, Mirzabekova FI. Changes in blood and lymph coagulation accompanying acute lower limb arterial occlusion. Bull Exp Biol Med 1990; 109: 332-333
    PubMedGoogle Scholar
  • 24 Le DT, Borgs P, Toneff TW, Witte MH, Rapaport SI. Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol 1998; 274 (3 Pt 2) H769-H776
    PubMedGoogle Scholar
  • 25 Miller GJ, Howarth DJ, Attfield JC , et al. Haemostatic factors in human peripheral afferent lymph. Thromb Haemost 2000; 83 (3) 427-432
    PubMedGoogle Scholar
  • 26 Leak LV, Liotta LA, Krutzsch H , et al. Proteomic analysis of lymph. Proteomics 2004; 4 (3) 753-765
    CrossrefPubMedGoogle Scholar
  • 27 Peltz ED, Moore EE, Zurawel AA , et al. Proteome and system ontology of hemorrhagic shock: exploring early constitutive changes in postshock mesenteric lymph. Surgery 2009; 146 (2) 347-357
    CrossrefPubMedGoogle Scholar
  • 28 Laschinger CA, Johnston MG, Hay JB, Wasi S. Production of plasminogen activator and plasminogen activator inhibitor by bovine lymphatic endothelial cells: modulation by TNF-alpha. Thromb Res 1990; 59 (3) 567-579
    CrossrefPubMedGoogle Scholar
  • 29 Leak LV, Saunders M, Day AA, Jones M. Stimulation of plasminogen activator and inhibitor in the lymphatic endothelium. Microvasc Res 2000; 60 (3) 201-211
    CrossrefPubMedGoogle Scholar
  • 30 Yamakawa M, Takagi M, Tajima K , et al. Localization of blood coagulation factors and fibrinolysis factors within lymphoid germinal centers in human lymph nodes. Histochemistry 1991; 96 (2) 123-127
    CrossrefPubMedGoogle Scholar
  • 31 Kudo S, Yamakawa M, Imai Y, Tsukamoto M. Localization of blood coagulation factors in the germinal centers of human Peyer’s patches. Histol Histopathol 1992; 7 (2) 175-181
    PubMedGoogle Scholar
  • 32 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34 (8) 747-761
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009; 35 (7) 695-710
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Lippi G, Franchini M, Favaloro EJ. Unsuspected triggers of venous thromboembolism—trivial or not so trivial?. Semin Thromb Hemost 2009; 35 (7) 597-604
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Favaloro EJ, Lippi G, Franchini M. Coagulopathies and thrombosis: usual and unusual causes and associations, part III. Semin Thromb Hemost 2010; 36 (1) 1-5
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Lippi G, Favaloro EJ, Franchini M. Coagulopathies and thrombosis: usual and unusual causes and associations, part IV. Semin Thromb Hemost 2011; 37 (3) 175-180
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 2011; 8 (9) 502-512
    CrossrefPubMedGoogle Scholar
  • 38 Fader R, Ewert A, Folse D. Thrombus formation in lymphatic vessels associated with Brugia malayi. Lymphology 1984; 17 (1) 3-9
    PubMedGoogle Scholar
  • 39 Fader RC, Ewert A. Evolution of lymph thrombi in experimental Brugia malayi infections: a scanning electron microscopic study. Lymphology 1986; 19 (4) 146-152
    PubMedGoogle Scholar
  • 40 Shin WS, Rockson SG. Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci 2008; 1131: 50-74
    CrossrefPubMedGoogle Scholar
  • 41 Meadows J, Gauvreau K, Jenkins K. Lymphatic obstruction and protein-losing enteropathy in patients with congenital heart disease. Congenit Heart Dis 2008; 3 (4) 269-276
    CrossrefPubMedGoogle Scholar
  • 42 Franchini M, Montagnana M, Favaloro EJ, Lippi G. The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Semin Thromb Hemost 2009; 35 (7) 644-653
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Paiva DM, Leite IC, Rodrigues VdeO, Cesca MG. [Associated factors of lymphedema in breast cancer patients]. Rev Bras Ginecol Obstet 2011; 33 (2) 75-80
    PubMedGoogle Scholar
  • 44 de Kroon KE, Roumen RM. [Diagnostic image (184). Two women with painful bands after axillary lymph node removal. Lymphatic thrombosis and fibrosis]. Ned Tijdschr Geneeskd 2004; 148 (15) 729
    PubMedGoogle Scholar
  • 45 Marcus RT, Pawade J, Vella EJ. Painful lymphatic occlusion following axillary lymph node surgery. Br J Surg 1990; 77 (6) 683
    CrossrefPubMedGoogle Scholar
  • 46 Moskovitz AH, Anderson BO, Yeung RS, Byrd DR, Lawton TJ, Moe RE. Axillary web syndrome after axillary dissection. Am J Surg 2001; 181 (5) 434-439
    CrossrefPubMedGoogle Scholar
  • 47 Keeley V. Classification of lymphoedema. In: Twycross R, Jenns K, Todd J, , eds. Lymphoedema. Oxford: Radcliffe Medical Press; 2000: 22-43
    Google Scholar
  • 48 Robless P, Lim J, Geroulakos G. Lymphoedema. Surgery 2010; 28: 268-272
    CrossrefPubMedGoogle Scholar
  • 49 Pfarr KM, Debrah AY, Specht S, Hoerauf A. Filariasis and lymphoedema. Parasite Immunol 2009; 31 (11) 664-672
    CrossrefPubMedGoogle Scholar
  • 50 Allen EV, Ghormley RK. Lymphedema of the extremities: etiology, classification and treatment; report of 300 cases. Ann Intern Med 1935; 9: 516-539
    PubMedGoogle Scholar
  • 51 Dumont AE, Clauss RH, Reed GE, Tice DA. Lymph drainage in patients with congestive heart failure. comparison with findings in hepatic cirrhosis. N Engl J Med 1963; 269: 949-952
    CrossrefPubMedGoogle Scholar
  • 52 Witte MH, Dumont AE, Clauss RH, Rader B, Levine N, Breed ES. Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation 1969; 39 (6) 723-733
    CrossrefPubMedGoogle Scholar
  • 53 Chan JC, Ganopolsky JG, Cornelissen I , et al. The characterization of mice with a targeted combined deficiency of protein c and factor XI. Am J Pathol 2001; 158 (2) 469-479
    CrossrefPubMedGoogle Scholar
  • 54 Moskalik KG, Alexeeva LN, Novik VI, Demin EV, Kozlov AP. Morphological changes in human skin melanoma treated by high-energy pulsed neodymium laser radiation. J BUON 2011; 16 (2) 341-344
    PubMedGoogle Scholar
  • 55 Hinckley ME. Thoracic-duct thrombosis with fatal chylothorax caused by a long venous catheter. N Engl J Med 1969; 280 (2) 95-96
    CrossrefPubMedGoogle Scholar
  • 56 Narayan P, Rahaman N, Molnar TF, Caputo M. Chylothorax following cardiac surgery caused by unusual lymphatic anatomy. Asian Cardiovasc Thorac Ann 2007; 15 (5) e58-e59
    PubMedGoogle Scholar
  • 57 Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009; 84 (2) 129-133
    CrossrefPubMedGoogle Scholar
  • 58 Baim S, Samuelson CO, Ward JR. Rheumatoid arthritis, amyloidosis, and chylous effusions. Arthritis Rheum 1979; 22 (2) 182-185
    CrossrefPubMedGoogle Scholar